SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-19-021281
Filing Date
2019-04-15
Accepted
2019-04-15 11:28:09
Documents
11
Period of Report
2019-06-13
Effectiveness Date
2019-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a19-3008_3def14a.htm DEF 14A 367376
3 GRAPHIC g30083bii001.gif GRAPHIC 4783
4 GRAPHIC g30083bii002.gif GRAPHIC 2701
5 GRAPHIC g30083bii003.gif GRAPHIC 1628
6 GRAPHIC g30083bii004.jpg GRAPHIC 2187
7 GRAPHIC g30083bii005.gif GRAPHIC 78
8 GRAPHIC g30083bii006.gif GRAPHIC 583
9 GRAPHIC j1930084_aa001.jpg GRAPHIC 6315
10 GRAPHIC g30083bki001.gif GRAPHIC 1347
11 GRAPHIC g30083bki002.gif GRAPHIC 199
12 GRAPHIC g30083cci001.gif GRAPHIC 2224
  Complete submission text file 0001104659-19-021281.txt   400280
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 811-06565 | Film No.: 19747949